Sonoma Pharmaceuticals Logo

Press Releases

Investors
  • Overview
  • Business Development
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Sonoma Pharmaceuticals and MicroSafe Group Announce that Health Canada Authorized Nanocyn® Disinfectant & Sanitizer to be Sold in Canada as a Hard-Surface Disinfectant under COVID-19 Interim Measure

Sep 17, 2020

Sonoma Pharmaceuticals and Te Arai BioFarma Announce Launch of Two New Microcyn® Technology Products in Australia – Nasocyn® Nasal Care and Oracyn® Oral Care

Sep 9, 2020

Sonoma Pharmaceuticals Reports First Quarter 2021 Financial Results

Aug 14, 2020

Sonoma Pharmaceuticals and MicroSafe Group Announce That Microsafe® Disinfectant & Sanitizer Manufactured Using Sonoma’s Microcyn® Technology Successfully Passed Material Compatibility Testing for Both Airbus and Boeing Commercial Transport Aircraft

Jul 28, 2020

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2020 Financial Results

Jul 10, 2020

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19

May 28, 2020

Sonoma Pharmaceuticals Announces Expanded Distribution Agreement with Brill International S.L. for Europe and approval of new CE Marking for Microdacyn60® Eye Care

May 26, 2020

Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group

Feb 27, 2020

Sonoma Pharmaceuticals Reports Third Quarter FY 2020 Financial Results

Feb 14, 2020

Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division

Jan 23, 2020
RSS
    • 1...
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • ...43
    Next